More Than 10 Million Adults Already Affected by “Tridemic”; Real-Time Oxygen Saturation Monitoring of At-Risk Patients Can Help Prevent Adverse Events

With many healthcare organizations dealing with the triple threat of rising cases of flu,  respiratory syncytial virus (RSV), and COVID, there has never been a more important time to monitor at-risk patients in real-time. With Smart Meter’s iPulseOx, the world’s first cellular-enabled pulse oximeter, providers can instantly see a person’s oxygen saturation level and take steps necessary to help prevent adverse events.

The CDC has recorded at least 8.7 million cases of flu, including 78,000 hospitalizations and 4,500 deaths, since October, according to published reports. Each year, it is estimated that between 60,000-120,000 older adults in the United States are hospitalized and 6,000-10,000 of them die due to RSV infection1. Meanwhile, COVID cases also continue to increase. For the first week of December, there was a 22 percent increase in cases as compared to the previous two weeks.2

"The combination of surging flu, RSV, and COVID-19 cases is pushing hospitals past their current ICU bed capacity," health officer and state epidemiologist at Oregon Health Authority Dean Sidelinger, MD, said in a press briefing on Dec. 8. "This year's influenza season has begun earlier than it normally does, and we are seeing high levels of influenza nationwide."

All these illnesses affect the respiratory system, can lead to more serious health issues and can become life threatening. People who are 65 years or older are at the greatest risk of complications and death from the flu. The CDC estimates that these people make up 54 to 70 percent of flu-related hospital visits.

When a physician has real-time oxygen saturation readings, they can make immediate decisions regarding their patients. Transmission of readings from the iPulseOx is sent via an exclusive 4/5G AT&T network so a provider knows they are getting the most immediate and accurate data possible from their patient.

“Smart Meter’s nationwide network of SmartPartnersTM work directly with care providers delivering real-time health data using remote patient monitoring for patients with respiratory disorders,” said Bill Bassett, Smart Meter’s Chief Marketing Officer. “SmartPartnersTM leverage exclusive cellular connectivity built into our iPulseOx solution, simplifying how patients measure their oxygen saturation readings without needing to log the results, which helps patients increase their testing adherence and provides physicians with accurate data for better intervention management.”

About Smart Meter, LLC
Smart Meter is the number one supplier of Remote Patient Monitoring (“RPM”) solutions to a nationwide network of SmartPartners™ who are transforming patient care. Millions of vital health data readings are reliably delivered across our platform enabling SmartPartners™ to deliver real-time, better-informed health care. Our proprietary, patient-friendly, cellular, FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1 RSV is on the rise among older adults as the hospitalization rate climbs to 10 times higher than usual (yahoo.com)

2 U.S. COVID cases are climbing again as new omicron variants spread - MarketWatch

 

Sixty-Three Percent of Adults with Type 2 Diabetes Can’t Send their Glucose Test Results to their Provider

The results of the Diabetes Care Survey, a longitudinal analysis of patients with Type 2 diabetes in the United States, have been released for 2022, providing insights into how remote patient monitoring (RPM) can benefit patients with chronic conditions. Although remote blood glucose monitoring (RBGM) has surged in the last couple of years, 63 percent of the people surveyed said their glucometer does not send their glucose reading to their provider.

According to the Centers for Disease Control and Prevention, 37.3 million people have diabetes, representing 11.3 percent of the US population. Of these, approximately 90 to 95 percent have type 2 diabetes.

One study found that about 45 percent of people with Type 2 diabetes don’t adequately control their glucose levels.1 Testing their glucose and knowing their reading on a regular basis can help these patients and their physician better manage their disease. Without test results automatically being sent to their doctor, patients still have the laborious task of writing down their readings and then remembering to take them to their next doctor’s appointment.

“Written glucose logs, some research postulates, are inaccurate or falsified up to 50% of the time,” said Ronald Tamler, MD, PhD, CDE, clinical director of the Mount Sinai Diabetes Center and associate professor of medicine at The Mount Sinai Medical Center.2 “Having this specific information allows your care provider to treat your diabetes better. But with so little patients bringing what is probably the most important tool in their management of diabetes, what is a physician to do?”

With cellular-enabled RBGM solutions, providers are assured of receiving reliable, dependable, and accurate data every time a patient tests their blood glucose. This can help identify trends, prevent hospitalization, and improve outcomes. Remote blood glucose monitoring is also reimbursable for providers.

“Smart Meter’s nationwide network of SmartPartnersTM work directly with care providers delivering real-time health data using remote patient monitoring for patients with chronic conditions, including Type 2 diabetes,” said Bill Bassett, Smart Meter’s Chief Marketing Officer. “SmartPartners leverage exclusive cellular connectivity built into our iGlucose Diabetes Management Solution, simplifying how patients measure their glucose readings without needing to log the results or wear bulky, uncomfortable equipment. Remote blood glucose monitoring helps patients increase their testing adherence and provides physicians with accurate data for better intervention management.”

Currently, any organization can receive $20 for every Bluetooth-enabled or competitive cellular-enabled device you replace with a Smart Meter cellular-enabled device, including the iGlucose for people with Type 2 diabetes.

You can view the complete results of the Diabetes Care Survey here.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1 Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors - PMC (nih.gov)

2 Doctors Want To See Your Glucose Meter | Prevention

Forty-Seven Percent of Persons With Type 2 Diabetes Say a Remote Patient Monitoring (RPM) Program Would Help Them Better Manage Their Health

The results of the Diabetes Care Survey, a longitudinal analysis of patients with Type 2 diabetes in the United States, have been released for 2022 and provide important insights into how remote patient monitoring (RPM) can benefit patients with chronic conditions. One of the most important findings was that 47 percent of patients surveyed said they would test their glucose more consistently if they knew the results were being transmitted to their provider.

And that 47 percent is an increase of 12 percent from last year’s survey. This coincides with the fact that RPM has become more popular with both providers and patients because it increases patient adherence and can help improve outcomes.

Approximately 26 million Americans have Type 2 diabetes, but according to one study, about 45 percent of them don’t adequately control their glucose levels.1 Testing their glucose and knowing their reading on a regular basis can help people with Type 2 diabetes and their physician better manage their disease.

Still, many people with Type 2 diabetes only see their doctor once or twice a year. If the patient is solely responsible for writing down their readings for review by their physician during an office visit, there may be an issue with those readings.

“Written glucose logs, some research postulates, are inaccurate or falsified up to 50% of the time,” said Ronald Tamler, MD, PhD, CDE, clinical director of the Mount Sinai Diabetes Center and associate professor of medicine at The Mount Sinai Medical Center.2 “Having this specific information allows your care provider to treat your diabetes better. But with so little patients bringing what is probably the most important tool in their management of diabetes, what is a physician to do?”

With cellular-enabled remote glucose monitoring solutions, providers are assured of getting the latest and most accurate data when a patient tests. This can help identify trends, prevent hospitalization, and improve outcomes.

“When patients use a cellular-enabled glucose meter, they know their results are being sent immediately to their provider,” said Dr. Bill Lewis, a national telemedicine consultant and prior Chair of the Telemedicine Accreditation Committee. “Smart Meter’s iGlucose is powered by an exclusive 4/5G AT&T network so transmission of data is fast, accurate, and secure every time.”

You can view the complete results of the Diabetes Care Survey here.

About Smart Meter, LLC

Smart Meter is the trusted supplier of Remote Patient Monitoring (“RPM”) solutions. We empower a nationwide network of SmartPartnersTM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

1 Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors - PMC (nih.gov)

2 Doctors Want To See Your Glucose Meter | Prevention

More Than 16 Million Americans Suffer from Chronic Obstructive Pulmonary Disease and About 50 Percent of Them Also Have Pulmonary Hypertension

TAMPA, Fla. -- Smart Meter continues to transform the remote patient monitoring (RPM) ecosystem, because of its superior cellular-enabled devices and robust data that facilitate better care management. Because Smart Meter can deliver reliable readings, better data, and better outcomes, we continue to be the trusted leader in chronic care management solutions for our RPM partners.

A Chronic Obstructive Pulmonary Disorder (COPD) study regarding the worldwide burden of the disease was released a few months ago and the conclusions were not positive for the United States, which was in the highest rate of prevalence per 100,000 people worldwide.1 Having COPD can also cause the arteries that bring blood to the lungs to thicken, leading to pulmonary hypertension. Approximately 50 percent of COPD patients have pulmonary hypertension.2

"COPD is a major public health problem with extensive healthcare and economic costs."  the authors of the worldwide study wrote. “With an aging population, COPD will continue to become an even greater problem in the future.”

Smart Meter’s cellular-enabled iPulseOx is an effective and efficient method for helping patients with COPD better manage their health. The easy-to-use iPulseOx transmits the patient’s oxygen saturation levels immediately through the reliable and secure AT&T IoT network to their provider. Real-time measurements help providers to make timely, better-informed care management decisions.

In addition, Smart Meter’s iBloodPressure blood pressure monitor is an easy way for hypertension patients to test and send their readings to their providers. This relieves patients of the burden of writing readings down and taking them to their next office visit.

“With these two innovative devices from Smart Meter, our customers are able to expand their solutions to the healthcare industry,” said Casey Pittock, Smart Meter’s CEO. “Our unique cellular technology facilitates the delivery of reliable, accurate patient testing data seamlessly to healthcare professionals via our customers’ platforms.”

About Smart Meter, LLC
Now serving more than 100,000 patients and transmitting 1.5 million patient test a month to our customers, Smart Meter is the leading, trusted supplier of cellular-enabled virtual care technologies that include the iGlucose®, iBloodPressure®, iPulseOx®, iScale®, and SmartRPMTM cloud platform, as well as data, and services. Smart Meter’s remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1 Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019 | The BMJ

2 Pulmonary hypertension in COPD: pathophysiology and therapeutic targets - PubMed (nih.gov)

Smart Meter’s Launches New Patient Engagement Program that is 94% Effective in Helping Improve Patient Adherence

TAMPA, Fla. -- Smart Meter announces the introduction of a breakthrough service, SmartTouch, that will improve patient adherence. The turnkey program uses omnichannel touchpoints to support patients in successfully using their cellular-enabled monitors and promotes ongoing testing adherence.

The SmartTouch program provides a valuable service supporting care management by delivering consistent reliable testing data to providers. For example, most people with Type 2 diabetes are required to test their blood glucose levels on a regular basis but many don’t follow the direction of their provider, even when enrolled in an RPM program. For patients with other chronic conditions, up to 60 percent are not adherent to their care plan. 1 The SmartTouch program bridges this gap for RPM programs improving the connection between patient and provider.

“I have been in the connected health industry for more than 20 years and SmartTouch could be the most impactful service offering ever to guarantee patient engagement with prescribed clinical monitoring,” said Smart Meter CEO Casey Pittock. “The biggest pain point in the healthcare industry – engaging patients to adhere to their care plan—is solved with SmartTouch. We have proven 94% adherence with this simple, effective, and affordable program to help patients develop habits of managing their health.”

Smart Meter partners who enroll their patients in the program will be guaranteed the requirements needed for reimbursement using CPT codes 99453 and 99454 with be achieved. If not, partners will not be billed for patients not achieving the requirements. More about the program can be found at www.smartmeterrpm.com or call 813-773-4080

About Smart Meter, LLC
Now serving more than 100,000 patients, Smart Meter is the leading supplier of cellular-enabled virtual care technologies that include the iGlucose®, iBloodPressure®, iPulseOx®, iScale®, and SmartRPMTM cloud platform, as well as data, and services. Smart Meter’s remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1 – McKinsey & Company study 2018

With High Blood Pressure being the No. 1 Controllable Risk Factor for Stroke, Smart Meter Can Help Patients During Stroke Awareness Month

Smart Meter's iBloodPressure Can Help Reduce the More than 795,000 Americans that Suffer from Strokes Each Year by Tracking Measurements in Real Time

TAMPA, Fla., May 16, 2022 -- Smart Meter, continues to lead the way in the remote patient monitoring (RPM) sector because of its superior cellular-enabled devices and robust data. During Stroke Awareness Month, Smart Meter wants to remind patients and providers that high blood pressure, which can lead to strokes, can be controlled, but it must be measured on a regular basis in order to spot trends and make diet and lifestyle adjustments.

According to the American Stroke Association1, nearly half of American adults have high blood pressure or hypertension (measurements higher than 120/80), but many don't even know it and that is why it is called the "silent killer." Actually, the risk of stroke increases at blood pressure levels above 115/75 mm Hg, and high blood pressure (BP) is the most important modifiable risk factor for stroke, associated with 54% of episodes of stroke worldwide2.

In a recent article from the Mayo Clinic, its staff advised that "home monitoring can help you keep tabs on your blood pressure, make certain your lifestyle changes are working, and alert you and your doctor to potential health complications. Talk to your doctor about home monitoring before you get started."3

Providing at-risk patients with an easy way to measure their blood pressure at home is the key to developing a habit of testing. Smart Meter can provide the technology needed to help improve outcomes.

"With Smart Meter's reliable and easy-to-use iBloodPressure® monitor, patients are more likely to test frequently, giving their healthcare professional real-time insight into current blood pressure readings, said Casey Pittock, Smart Meter's CEO. "We have seen firsthand the positive impact on patient outcomes when our cellular-enabled iBloodPressure monitor is used in a remote patient monitoring (RPM) program."

The iBloodPressure is one of Smart Meter's most popular devices because it features a 4/5G cellular connectivity via the secure and reliable AT&T IoT network. Once the patient has tested using the iBloodPressure system, the results are transmitted immediately to a provider, with no syncing or pairing required by the patient.

About Smart Meter, LLC
Now serving more than 100,000 patients, Smart Meter is the leading supplier of cellular-enabled virtual care technologies that include the iGlucose®, iBloodPressure®, iPulseOx®, iScale®, and SmartRPM™ cloud platform, as well as data, and services. Smart Meter's remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1High Blood Pressure and Stroke | American Stroke Association
2Blood Pressure Control and Primary Prevention of Stroke: Summary of the Recent Clinical Trial Data and Meta-Analyses - PMC (nih.gov)
310 ways to control high blood pressure without medication - Mayo Clinic

Smart Meter, LLC    
5501 W. Waters Ave., Suite 401           
Tampa, FL 33634                                 
813-773-4080

Media Contact
Keith Tolbert
keith.tolbert@iglucose.com
336-509-8024

Smart Meter's iBloodPressure® and iScale® can Help Patients and Providers Track Key indicators of Heart Issues in Real Time

Studies have linked hypertension and obesity to various heart issues

TAMPA, Fla., April 13, 2022 -- Smart Meter, a leader in remote patient monitoring (RPM) solutions, helps RPM providers deliver disease and condition-specific products and services to healthcare providers. Cardiovascular Disease (CVD) was responsible for more than 19 million deaths worldwide in 2020. The iBloodPressure® and iScale® from Smart Meter provide an immediate way in which RPM companies can help provide support to this large population of patients working to control their hypertension and weight to avoid more serious issues.

In one study it was observed that overweight individuals had a moderately higher risk of CVD in both the weight loss and the weight gain group, compared with maintenance. In the obese, those losing weight showed lower risk of coronary heart disease. And among individuals with obesity, the weight-loss group had a lower risk of coronary heart disease.1

Another study revealed a modest weight loss improves clinical control over CVD risk factors in individuals remaining at risk of being overweight or obese. Weight loss of 5–10% allows clinically significant improvement in blood pressure, HDL-C cholesterol fraction, (but not LDL-C), triglycerides, and fasting glycemia. Since even in the short term a modest weight loss stands to significantly improve individual health outcomes, this method should routinely be recommended as an effective strategy, principally aimed at reducing overall CVD risk.2

"We're becoming more and more aware of the importance of high blood pressure. Levels we used to think were normal we now associate with worse outcomes, and treating them makes a big difference," said Dr. Emelia J. Benjamin, a professor of cardiology at Boston University and chair of the group that wrote the American Heart Association's "Heart Disease and Stroke Statistics-2019 Update".3

Smart Meter's iBloodPressure and iScale are the perfect devices for providers who want to track a patient's results in real time. Both these devices transmit across a 4/5G tunnel, using AT&T IoT technology that provides reliable and secure delivery of a patient's blood pressure and weight immediately after testing so healthcare providers can spot out-of-range trends and make appropriate changes to a patient's care plan. The data can be viewed in Smart Meter's portals for patients and providers or can be integrated into almost any remote patient monitoring software or electronic health record software.

About Smart Meter, LLC
Smart Meter is the leading supplier of cellular-enabled virtual care technologies that include the iGlucose®, iBloodPressure®, iPulseOx®, iScale®, and SmartRPM™ cloud platform, as well as data, and services. Now serving more than 100,000 patients, Smart Meter's remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1 DOI: 10.1097/EDE.0000000000001393 Weight Change and the Onset of Cardiovascular Diseases: Emul... : Epidemiology (lww.com)

2A Two-Year Follow-Up Cohort Study—Improved Clinical Control over CVD Risk Factors through Weight Loss in Middle-Aged and Older Adults - PMC (nih.gov)

3Cardiovascular diseases affect nearly half of American adults, statistics show | American Heart Association

 

Smart Meter's iPulseOx can help track Long COVID patients' oxygen saturation levels

Hundreds of healthcare professionals at HIMSS were impressed with our 4/5G cellular-connected devices that utilize the AT&T IoT Network for fast and reliable data transmission

TAMPA, Fla. --

Smart Meter, continues to lead the way in remote patient monitoring (RPM) solutions, helping RPM providers deliver disease and condition specific products and services to healthcare providers. The iPulseOx® is an immediate way in which RPM companies can support caring for the growing number of patients afflicted with Long COVID. During the recent HIMSS Show, Smart Meter received overwhelming support for the iPulseOx and its entire line of cellular-enabled physiologic monitoring devices from healthcare systems, physician practices, IT professionals and payors from around the globe.

For many healthcare professionals, HIMSS was an opportunity to find resources to help them continue to navigate in a COVID-19 world. It is now estimated that 111 million Americans suffer from Long COVID symptoms, which may include shortness of breath. One study2 of post-COVID survivors revealed that "23.5 percent had significant impairment of diffusion capacity abnormality of lung function."

"As the remote patient monitoring sector is evolving into more areas of chronic care management, Smart Meter continues to lead the way with its data and devices," said Casey Pittock, CEO of Smart Meter. "Our cellular devices, robust data and consistent commitment to helping our partners succeed have led to incredible growth and our ability to develop cutting-edge technology, like the iPulseOx."

Smart Meter's iPulseOx is the perfect device for providers who want to track a patient's oxygen saturation level in real-time. The iPulseOx transmits across a 4/5G tunnel, using AT&T IoT technology that provides reliable and secure delivery of a patient's oxygen saturation levels immediately after testing so healthcare providers can see trends and make appropriate changes to a patient's care plan. The data can be viewed in Smart Meter's portals for patients and providers or can be integrated into almost any remote patient monitoring software or electronic health record software.

The iPulseOx is small and lightweight and comes with a carrying pouch and a lanyard to help prevent patients from misplacing it. In addition, the iPulseOx is easy for anyone to use because there are no wires and all it takes is for the patient to turn the device on and to properly insert their finger to receive immediate results.

About Smart Meter, LLC
Smart Meter is the leading supplier of cellular-enabled virtual care technologies that include the iGlucose, iBloodPressure, iPulseOx, iScale, and SmartRPM cloud platform, as well as data, and services. Now serving more than 100,000 patients, Smart Meter's remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1Estimates of Americans with long COVID-19, per state (beckershospitalreview.com)
2Long-term COVID-19 effects on pulmonary function, exercise capacity, and health status - PMC (nih.gov)
®

Smart Meter to Launch High Performance Cellular iBloodPressure 2.0™ at HIMSS

Smart Meter Remote Patient Monitoring Devices Powered by AT&T IoT Connectivity

TAMPA, Fla. --

What's the news?  Smart Meter, a leader in cellular-enabled remote patient monitoring (RPM) devices and services will unveil its new iBloodPressure 2.0™ developed jointly with A&D Medical at HIMSS March 14 to 18, 2022 in Orlando. AT&T will simultaneously feature all of Smart Meter's health monitors on its Healthcare Tech Innovation Wall, an interactive display of cellular-enabled devices.

iBloodPressure 2.0 is the only blood pressure monitor assembled in the USA with AT&T 4/5G LTE cellular and enhanced CAT-M for secure, dependable, real-time data transmission from patient to physician. The iBloodPressure 2.0 contains an AT&T IoT SIM card, so the device automatically sends a patient's data over the AT&T IoT network to the SmartRPM™ cloud. The healthcare provider then accesses the data there via secure log-in. The iBloodPressure 2.0 was designed together with A&D Medical, known for their high-quality medical devices that are clinically validated for accuracy.

iBloodPresssure 2.0 joins the Smart Meter suite of products utilizing the secure and broad-reaching AT&T IoT cellular network including iGlucose®, iScale™, iPluseOx™ and the SmartRPM™ cloud. All Smart Meter devices transmit data upon the first use without the need for training, syncing, apps, Wi-Fi, internet, or smartphones.

Why is this important? Hypertension can lead to two of the biggest killers in this country – heart disease and stroke - and consequently home blood pressure monitoring is recommended by major guidelines and reliable home blood pressure monitors are often requested by physicians for RPM programs.

What are the benefits? Studies show remote patient monitoring can contribute to clinically significant improvements in blood pressure.1 Over a 12-week period, 88% of critical stage II hypertensive patients using iBloodPressure™ as part of RPM programs experienced reductions in blood pressure.2

What people are saying

"We listened to our customers who wanted accuracy and precision in both the quality of the readings, as well as the data transmission, and iBloodPressure 2.0 delivers on both counts, resulting in improved care and complete RPM billing data." Said Casey Pittock, CEO of Smart Meter. "Our co-development partner A&D Medical is perhaps the world's highest quality blood pressure manufacturer, which, when combined with the reliability of AT&T IoT Connectivity means iBloodPressure 2.0 is poised to become a leading RPM product," Casey added.

"Providing connectivity for solutions that give easy access to improved healthcare is what we're about," said Joe Drygas, VP of AT&T Healthcare Solutions. "Our collaboration with Smart Meter is another example of how AT&T IoT connectivity is advancing connected healthcare."

"The collaboration between A&D Medical, Smart Meter and AT&T brings advanced healthcare to a broader population with a best-in-class solution improving reliability, connectivity and accuracy of remote patient monitoring," said Greg Lillegard, COO for A&D Medical.

About Smart Meter, LLC
Smart Meter is the leading supplier of cellular-enabled virtual care technologies including the iGlucose™, iBloodPressure™, iScale™, iPulseOx™, and SmartRPM™ cloud platform, data, and services. Smart Meter's remote patient monitoring solutions are recognized as the standard for the remote patient monitoring industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, Chronic Care Management (CCM), Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

1HelloHeart Study https://www.helloheart.com/news/jama-study-of-over-28-000-participants-finds-84-of-hello-heart-users-reduced-blood-pressure-over-three-years

Smart Meter Introduces the iPulseOx Powered by AT&T IoT Connectivity

The world’s first cellular-connected pulse oximeter facilitates remote monitoring for 67 million patients with chronic diseases.

TAMPA, Fla. -- Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices, announces the release of the iPulseOxTM, the world’s first cellular-connected pulse oximeter, furthering the transformation of remote patient monitoring services for chronic conditions such as chronic obstructive pulmonary disease (COPD) and heart disease.

The American Lung Association estimates as many as 37 million Americans suffer from chronic lung disorders like asthma and COPD.1 The Centers for Disease Control estimate there are 30.3 million who have heart disease.2   There are millions more suffering from complications of post-COVID infections.  More than ever, the use of remote monitoring of a patient’s oxygen saturation level (Sp02) has become an essential tool for care management.

The iPulseOx contains an AT&T IoT SIM card that automatically sends a patient’s testing data over the secured, reliable AT&T IoT network to the Smart Meter SmartRPM™ cloud. The healthcare provider can access the data via a HIPAA-secure log-in to view and track the patient’s oxygen saturation in real-time.

“Smart Meter is excited to add another product to our growing family of cellular-enabled remote monitoring solutions helping our partners expand their RPM programs to even more diseases and patients,” said Casey Pittock, CEO, Smart Meter. “Using the iPulseOx, patients and their providers are provided valuable insight to key health data for conditions such as COPD, Heart Failure, COVID, Asthma, and more.  This incredibly innovative product that incorporates our proprietary cellular technology expands our unique leadership role in the hyper-growth remote patient monitoring industry.”

The iPulseOx is small and lightweight and comes with a carrying pouch and a lanyard to help prevent patients from misplacing it. In addition, the iPulseOx is easy for anyone to use because there are no wires or need to connect via Bluetooth®. The patient only needs to turn the device on and properly insert their finger to receive immediate results.

About Smart Meter, LLC
Smart Meter is the leading supplier of cellular-enabled virtual care technologies, including the iGlucose, iBloodPressure, iScale, iPulseOx, SmartRPM cloud platform, data, and services. Smart Meter’s remote patient monitoring solutions are recognized as the standard for the RPM industry and are regarded for their high patient retention and satisfaction. The unique combination of reliable health data, patient-friendly devices, and platform integrations enable and enhance RPM, CCM, Employee Wellness, Population Health, and Telehealth programs for more than 300 RPM distribution partners across the United States. For more information, visit SmartMeterRPM.com

Footnotes